health care reform

Perspectives

06/14/2017

Abstract: Since its passage in 2010, the Patient Protection and Affordable Care Act (ACA) has caused widespread disruption in the US health care ecosystem. This has put a huge spotlight on the system’s shortcomings,...

...

06/14/2017

Journal of Clinical Pathways

Interview

The Shaping of Clinical Pathways Through User-Defined Value-Based Care

03/27/2017

JCP Editors

Journal of Clinical Pathways spoke with Alex W Bastian, MBA, strategic advisor, ASCO Value In Cancer Task Force, about how his role in the Task Force has impacted his views concerning...

...

03/27/2017

Journal of Clinical Pathways

Interview

The Ethical Implications of Rapid Learning Systems in Oncology

03/15/2017

JCP Editors

Health care providers and research scientists frequently utilize emerging technology to enhance their ability to study diseases and develop effective treatment. A major area of growth in medicine has surrounded the...

...

03/15/2017

Journal of Clinical Pathways

Editor's Page

A Look Into the Future: What`s Next for Pathways?

03/15/2017

Winston Wong , PharmD;

Health care delivery is always in flux, but treatment advances over the last several years have introduced new variables into the health care continuum that were unthinkable even a decade ago. Researchers, providers,...

Health...

03/15/2017

Journal of Clinical Pathways

Interview

Clinical pathways, value-based care amidst health care reform

02/27/2017

JCP Editors

Journal of Clinical Pathways spoke with Winston Wong, PharmD, editor-in-chief about the role of clinical pathways and value-based care in health care reform. What inspired you to go into your field? I wanted...

...

02/27/2017

Journal of Clinical Pathways

Interview

COA Speaks Out Against PBM Restrictions of Medication Access

10/12/2016

JCP Editors

CVS Caremark®, one of the leading pharmacy benefit managers (PBMs) in the United States, recently made a decision to restrict patient access to physician dispensing of medication directly to patients at their clinic...

CVS...

10/12/2016

Journal of Clinical Pathways

Research in Review

Five Strategies to Reduce MS Treatment Cost

10/12/2016

JCP Editors

The soaring in prices of disease-modifying therapies (DMTs) for multiple sclerosis (MS) over the last several years has resulted in significant increases in the costs of MS-related care. In a new study, published in...

The...

10/12/2016

Journal of Clinical Pathways

Research in Review

FDA Hematology-Oncology Reviewers Move on to Consult or Work for Biopharmaceutical Companies

09/30/2016

JCP Editors

Medical reviewers at the US Food and Drug Administration are an important part of regulating therapeutics and ensuring that patients have access to the right medications, but a recent letter published in BMJ has...

...

09/30/2016

Journal of Clinical Pathways

Research in Review

Value-Driven Outcomes Program Reduces Costs and Improves Quality

09/26/2016

JCP Editors

An analytic tool that allocates clinical care costs and quality measures to individual patient encounters may help to enhance the quality of care delivered by physicians, according to research published in JAMA. As...

An...

09/26/2016

Journal of Clinical Pathways

Counterpoint

The Pivot Toward Patient-Centeredness in Medicine and Oncology

09/06/2016

Jennifer Fillman , MBA;

Julia Braverman , PhD;

Bruce A. Feinberg , DO;

Patient-reported outcome (PRO) research has shown that PROs must play a role in the future of health care delivery as the system transitions from volume-based care to value-based care. Building trust among...

...

09/06/2016

Journal of Clinical Pathways